Brief: Valerio Therapeutics Enters Into Collaboration & Exclusive License With Seed-Stage Biotech Co
18/05/2026 17:32
May 18 (Reuters) - Valerio Therapeutics SA ALVIO.PA: VALERIO THERAPEUTICS ANNOUNCES BINDING TERM-SHEET FOR COLLABORATION AND EXCLUSIVE LICENSE WITH SEED-STAGE BIOTECH COMPANY VALERIO THERAPEUTICS SA: UNDER TERMS OF BINDING TERM-SHEET, CO TO RECEIVE PAYMENTS UP TO $200 MILLION, AS WELL AS TIERED ROYALTIES ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Valerio Therapeutics SA
See all newsBrief: Valerio Therapeutics To Buy Etherna Immunotherapies For €30 Mln
Brief: Valerio Therapeutics Signs Development Collaboration With Abivax
Brief: Valerio Therapeutics Enters Into Collaboration & Exclusive License With Seed-Stage Biotech Co
Brief: Onxeo Changes Its Name And Becomes Valerio Therapeutics
Brief: Onxeo H1 Net Loss Widens To EUR 11.5 Mln